目的：评价血瘫病（脑出血）诊疗方案的临床疗效和安全性，为进一步优化诊疗方案奠定基础。方法：42 例患者进行藏成药一个疗程的治疗（28 天），对治疗前后的疗效进行比较，观察患者的症候、体征、肝功、肾功、心电图，头颅CT 等指标。结果：治疗后，患者的症候、体征、头颅CT 指标具有明显的改善，具有统计学意义（P＜0.01）。治疗前后肝功、肾功未见明显异常，无显著性差异。结论：血瘫病的藏成药诊疗方案临床疗效确切，值得推广应用。

This study was aimed to evaluate clinical effect and safety for diagnosis and treatment plan of Xuetanbing (cerebral hemorrhage), and lay a foundation for further optimization of diagnosis and treatment plan. A total of 42 patients were treated with Tibetan patent medicine for one treatment course (28 days). And the pre -treatment and post -treatment clinical effects were compared through the observation on indexes such as symptoms, body signs, hepatic function, renal function, electrocardiogram (ECG), and head CT scan and so on.The results showed that indexes such as symptoms, body signs and head CT scan after treatment were obviously improved with statistical significance (P < 0.01). There were no obvious abnormalities on the hepatic function and renal function before and after treatment with no significant difference. It was concluded that the Tibetan patent medicine diagnosis and treatment plan of Xuetanbing has identified clinical effect and it is worth of popularization and application.

国家中医药管理局国家中医（民族医）临床研究基地建设项目（201303024005）：重点病种研究，负责人：巴桑卓玛。